Drug intelligence / Profile preview

MUCA

Development stage: Preclinical
Modality: Drug Delivery Systems
Administration: Transdermal

Overview

MUCA is a component of a spreadable gel formulation utilized within a high-efficiency transdermal delivery system. It is currently under investigation in a clinical trial as part of a combination therapy with 5-fluorouracil (5-FU) and SHS for the treatment of hypertrophic scars. The primary function of MUCA appears to be facilitating the transdermal delivery of active pharmaceutical ingredients.

Beyond the preview

Go deeper on MUCA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MUCA.

Explore the full profile